Multifaceted nature of membrane microdomains in colorectal cancer

World Journal of Gastroenterology

Volumn 17, Issue 6, 2011, Pages 681-690

  Jahn, Kristina A ^a   Su, Yingying ^a   Braet, Filip ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Actin; Caveolae; Combined imaging; Cytoskeleton; Detergent resistant membranes; Drug targeting; Electron microscopy; Lipid domains; Lipid mediated therapy; Membrane rafts; Prognosis; Staging; Tomography

Indexed keywords

CAVEOLIN; CD133 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; BENIGN TUMOR; BIOCHEMISTRY; CANCER CELL CULTURE; CELL ADHESION; CELL DEATH; CELL PROLIFERATION; COLORECTAL CANCER; DRUG RESISTANCE; ELECTRON MICROSCOPE; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; INTRACELLULAR SIGNALING; LIPID METABOLISM; LIPID RAFT; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 79955936569     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i6.681     Document Type: Article

References (71)

1. Owen DM, Williamson D, Rentero C, Gaus K. Quantitative microscopy: protein dynamics and membrane organisation. Traffic 2009; 10: 962-971
2. Yano Y, Matsuzaki K. Tag-probe labeling methods for livecell imaging of membrane proteins. Biochim Biophys Acta 2009; 1788: 2124-2131
3. Giepmans BN. Bridging fluorescence microscopy and electron microscopy. Histochem Cell Biol 2008; 130: 211-217
4. Müller SA, Aebi U, Engel A. What transmission electron microscopes can visualize now and in the future. J Struct Biol 2008; 163: 235-245
5. Morone N, Nakada C, Umemura Y, Usukura J, Kusumi A. Three-dimensional molecular architecture of the plasmamembrane- associated cytoskeleton as reconstructed by freezeetch electron tomography. Methods Cell Biol 2008; 88: 207-236
6. Astarita G, Ahmed F, Piomelli D. Lipidomic analysis of biological samples by liquid chromatography coupled to mass spectrometry. Methods Mol Biol 2009; 579: 201-219
7. Brown HA, Murphy RC. Working towards an exegesis for lipids in biology. Nat Chem Biol 2009; 5: 602-606
8. Marrink SJ, de Vries AH, Tieleman DP. Lipids on the move: simulations of membrane pores, domains, stalks and curves. Biochim Biophys Acta 2009; 1788: 149-168
9. Niemelä PS, Castillo S, Sysi-Aho M, Oresic M. Bioinformatics and computational methods for lipidomics. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 2855-2862
10. Hooke R. Micrographia: or, Some physiological descriptions of minute bodies made by magnifying glasses. With observations and inquiries thereupon. London: Royal Society, 1665: 246
11. Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science 1972; 175: 720-731
12. de Duve C. [Albert Claude and the beginnings of modern cell biology]. Cellule 1987; 74: 11-19
13. Escribá PV. Membrane-lipid therapy: a new approach in molecular medicine. Trends Mol Med 2006; 12: 34-43
14. Lipowsky R, Sackmann E. The structure and dynamics of membranes. Amsterdam: Elsevier, 1995
15. van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 2008; 9: 112-124
16. Fernandis AZ, Wenk MR. Membrane lipids as signaling molecules. Curr Opin Lipidol 2007; 18: 121-128
17. Palade GE, Simionescu M, Simionescu N. Structural aspects of the permeability of the microvascular endothelium. Acta Physiol Scand Suppl 1979; 463: 11-32
18. Simons K, van Meer G. Lipid sorting in epithelial cells. Biochemistry 1988; 27: 6197-6202
19. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569-572
20. Edidin M. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 2003; 32: 257-283
21. Matkó J, Söllosi J. Regulatory aspects of membrane microdomain (raft) dynamics in live cells. In: Mattson MP, editor. Membrane microdomain signaling - Lipid rafts in biology and medicine. Totowa, New Jersey: Humana Press, 2005: 15-46
22. Lindner R, Naim HY. Domains in biological membranes. Exp Cell Res 2009; 315: 2871-2878
23. Michel V, Bakovic M. Lipid rafts in health and disease. Biol Cell 2007; 99: 129-140
24. Ma DW. Lipid mediators in membrane rafts are important determinants of human health and disease. Appl Physiol Nutr Metab 2007; 32: 341-350
25. Patra SK. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 2008; 1785: 182-206
26. Schmitz G, Grandl M. Update on lipid membrane microdomains. Curr Opin Clin Nutr Metab Care 2008; 11: 106-112
27. Escribá PV, González-Ros JM, Goñi FM, Kinnunen PK, Vigh L, Sánchez-Magraner L, Fernández AM, Busquets X, Horváth I, Barceló-Coblijn G. Membranes: a meeting point for lipids, proteins and therapies. J Cell Mol Med 2008; 12: 829-875
28. Rakheja D, Kapur P, Hoang MP, Roy LC, Bennett MJ. Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function. Med Hypotheses 2005; 65: 1120-1123
29. Chapkin RS, McMurray DN, Lupton JR. Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 2007; 23: 48-54
30. Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998; 141: 905-915
31. Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O, Laurent G, Gambert P, Solary E, Dimanche- Boitrel MT. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res 2004; 64: 3593-3598
32. Rebillard A, Tekpli X, Meurette O, Sergent O, LeMoigne- Muller G, Vernhet L, Gorria M, Chevanne M, Christmann M, Kaina B, Counillon L, Gulbins E, Lagadic-Gossmann D, Dimanche-Boitrel MT. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res 2007; 67: 7865-7874
33. Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, Weinstein IB. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res 2007; 67: 6493-6501
34. Bacsó Z, Bene L, Damjanovich L, Damjanovich S. INFgamma rearranges membrane topography of MHC-I and ICAM-1 in colon carcinoma cells. Biochem Biophys Res Commun 2002; 290: 635-640
35. Liscovitch M, Burgermeister E, Jain N, Ravid D, Shatz M, Tencer L. Caveolin and cancer. In: Mattson MP, editor. Membrane microdomain signaling - Lipid rafts in biology and medicine. Totowa, New Jersey: Humana Press, 2005: 161-190
36. Lagerholm BC, Weinreb GE, Jacobson K, Thompson NL. Detecting microdomains in intact cell membranes. Annu Rev Phys Chem 2005; 56: 309-336
37. Jahn KA, Braet F. Monitoring membrane rafts in colorectal cancer cells by means of correlative fluorescence electron microscopy (CFEM). Micron 2008; 39: 1393-1397
38. Hahismoto S, Yazawa S, Asao T, Faried A, Nishimura T, Tsuboi K, Nakagawa T, Yamauchi T, Koyama N, Umehara K, Saniabadi AR, Kuwano H. Novel sugar-cholestanols as anticancer agents against peritoneal dissemination of tumor cells. Glycoconj J 2008; 25: 531-544
39. Harder T, Scheiffele P, Verkade P, Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 1998; 141: 929-942
40. Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther 2007; 6: 2591-2599
41. Calzolari A, Deaglio S, Maldi E, Cassoni P, Malavasi F, Testa U. TfR2 expression in human colon carcinomas. Blood Cells Mol Dis 2009; 43: 243-249
42. Delmas D, Rébé C, Micheau O, Athias A, Gambert P, Grazide S, Laurent G, Latruffe N, Solary E. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 2004; 23: 8979-8986
43. Harder T, Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol 1997; 9: 534-542
44. Hooper NM. Detergent-insoluble glycosphingolipid/cholesterol- rich membrane domains, lipid rafts and caveolae (review). Mol Membr Biol 1999; 16: 145-156
45. Schütz GJ, Kada G, Pastushenko VP, Schindler H. Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy. EMBO J 2000; 19: 892-901
46. Simons K, Vaz WL. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 2004; 33: 269-295
47. Wilson BS, Steinberg SL, Liederman K, Pfeiffer JR, Surviladze Z, Zhang J, Samelson LE, Yang LH, Kotula PG, Oliver JM. Markers for detergent-resistant lipid rafts occupy distinct and dynamic domains in native membranes. Mol Biol Cell 2004; 15: 2580-2592
48. Jahn KA, Barton DA, Su Y, Riches J, Kable EP, Soon LL, Braet F. Correlative fluorescence and transmission electron microscopy: an elegant tool to study the actin cytoskeleton of wholemount (breast) cancer cells. J Microsc 2009; 235: 282-292
49. Chichili GR, Rodgers W. Cytoskeleton-membrane interactions in membrane raft structure. Cell Mol Life Sci 2009; 66: 2319-2328
50. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 2009; 361: 1570-1583
51. Remacle-Bonnet M, Garrouste F, Baillat G, Andre F, Marvaldi J, Pommier G. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily. Am J Pathol 2005; 167: 761-773
52. Fine SW, Lisanti MP, Galbiati F, Li M. Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Pathol 2001; 115: 719-724
53. Kim HA, Kim KH, Lee RA. Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. Exp Mol Pathol 2006; 80: 165-170
54. Bender F, Montoya M, Monardes V, Leyton L, Quest AF. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol Res 2002; 35: 151-167
55. Henkhaus RS, Roy UK, Cavallo-Medved D, Sloane BF, Gerner EW, Ignatenko NA. Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Neoplasia 2008; 10: 140-148
56. Baillat G, Siret C, Delamarre E, Luis J. Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-dependent Akt signaling in SW480 colon cancer cells. Biochim Biophys Acta 2008; 1783: 2323-2331
57. Taïeb N, Maresca M, Guo XJ, Garmy N, Fantini J, Yahi N. The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. Cancer Lett 2009; 278: 164-173
58. Das M, Gherghiceanu M, Lekli I, Mukherjee S, Popescu LM, Das DK. Essential role of lipid raft in ischemic preconditioning. Cell Physiol Biochem 2008; 21: 325-334
59. Zaidi T, Bajmoczi M, Zaidi T, Golan DE, Pier GB. Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2008; 49: 1000-1009
60. Mollinedo F, Gajate C, Morales AI, del Canto-Jañez E, Justies N, Collía F, Rivas JV, Modolell M, Iglesias A. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis. J Pharmacol Exp Ther 2009; 329: 439-449
61. Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B. Regulation of vitamin D receptor expression via estrogeninduced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol 2005; 185: 577-592
62. Klappe K, Hinrichs JW, Kroesen BJ, Sietsma H, Kok JW. MRP1 and glucosylceramide are coordinately over expressed and enriched in rafts during multidrug resistance acquisition in colon cancer cells. Int J Cancer 2004; 110: 511-522
63. Le Naour F, André M, Boucheix C, Rubinstein E. Membrane microdomains and proteomics: lessons from tetraspanin microdomains and comparison with lipid rafts. Proteomics 2006; 6: 6447-6454
64. Fernandis AZ, Wenk MR. Lipid-based biomarkers for cancer. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 2830-2835
65. Mollinedo F, Gajate C. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat 2006; 9: 51-73
66. Vekemans K, Timmers M, Vermijlen D, De Zanger R, Wisse E, Braet F. CC531s colon carcinoma cells induce apoptosis in rat hepatic endothelial cells by the Fas/FasL-mediated pathway. Liver Int 2003; 23: 283-293
67. Vekemans K, Braet F, Muyllaert D, Wisse E. Nitric oxide from rat liver sinusoidal endothelial cells induces apoptosis in IFN gamma-sensitized CC531s colon carcinoma cells. J Hepatol 2004; 41: 11-18
68. Siddiqui RA, Harvey KA, Zaloga GP, Stillwell W. Modulation of lipid rafts by Omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support. Nutr Clin Pract 2007; 22: 74-88
69. Brown AJ. Cholesterol, statins and cancer. Clin Exp Pharmacol Physiol 2007; 34: 135-141
70. Biondo PD, Brindley DN, Sawyer MB, Field CJ. The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J Nutr Biochem 2008; 19: 787-796
71. Li Q, Zhang Q, Zhang M, Wang C, Zhu Z, Li N, Li J. Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis. FEBS J 2008; 275: 411-420